Cellistic

Cellistic specializes in process development and manufacture of cell therapies based on human induced pluripotent stem cell (iPSC) technology

[Cellistic @CellisticCT]

Happy to introduce @CellisticCT ! Cellistic leverages 10+ years of @Ncardia’s experience, offering unique capabilities for the design of proprietary manufacturing platforms for iPSC-based allogeneic #celltherapies

Learn more 👇https://t.co/zwWbet24UQ

[Cellistic @CellisticCT]

We are excited to be participating in this year's Cell and Gene Meeting on the Med, in Rome, Italy. Let's connect if you are attending to learn more about Cellistic's Pulse and Echo Platform that enable IPSC allogeneic cell therapies.
https://t.co/1z37ZveA2U

[Cellistic @CellisticCT]

The Cellistic team returned from ATW 2024 in Miami with promising takeaways on the future of cell and gene therapy. We shared many great conversations, and noticed a few key themes that could shape much of the work being done in 2024.
https://t.co/VxoTR1V6eo

[Cellistic @CellisticCT]

In Miami for Advanced Therapies Week? Join Elena Matsa at 3pm today in the Innovation Zone to discover Cellistic's approach to dealing with current manufacturing bottlenecks. You won't want to miss this!

https://t.co/hKq59Q7qM3

#ATW24 #iPSCs #celltherapy #stemcells

[Cellistic @CellisticCT]

Hello from Miami! We're having a great time at Advanced Therapies Week networking and sharing information about our new iPSC platforms Pulse and Echo.

If you're in town, stop by booth #323 - we'd love to connect!

https://t.co/VWInZbtiX3

#ATW24 #iPSCs #celltherapy #stemcells

[Cellistic @CellisticCT]

Advanced Therapies Week starts tomorrow! Learn about our Pulse + Echo platforms at Booth 323, come to our talk on cell therapy manufacturing bottlenecks on Thursday at 3, and schedule a time to meet 1-on-1: https://t.co/IowvZPVKET

#ATW24 #iPSCs #celltherapy #stemcells

[Cellistic @CellisticCT]

Advanced Therapies Week starts tomorrow! Learn about our Pulse + Echo platforms at Booth 323, come to our talk on cell therapy manufacturing bottlenecks on Thursday at 3, and schedule a time to meet 1-on-1: https://t.co/yy3TJSs5nd

#ATW24 #iPSCs #celltherapy #stemcells

[Cellistic @CellisticCT]

#ATW24 is a week away. Come see Cellistic at Booth 323 and hear our talk on dealing with cell therapy manufacturing bottlenecks on 1/18 at 3pm. Get all the details and schedule a time to meet with us in Miami Beach: https://t.co/z7ON9dGv7i

#iPSCs #celltherapy #stemcells

[Cellistic @CellisticCT]

Join us at Booth 323 in Miami Beach 1/16-19 to talk with Jonas Mortenson and Elena Matsa about accelerating your promising cell therapy programs using our iPSC-based platforms. And come hear our talk in the Innovation Zone 1/18 at 3pm.

https://t.co/pEq1RnMMYQ

#ATW24 #iPSC

[Cellistic @CellisticCT]

Excited for Advanced Therapies Week 2024!

Visit booth #323 to meet Jonas Mortensen & Elena Matsa. Be sure to catch our presentation at the Innovation Zone on January 18 at 3 p.m!

Schedule a meeting here: https://t.co/7JN0gETznm

#ATW #iPSCs #celltherapy #stemcells

[Cellistic @CellisticCT]

You’ve come too far and invested too much to see your innovation struggle. Leverage the world’s first facility purpose-built for iPSC-based allogeneic cell therapy manufacturing, powered with a 120-strong team of iPSC experts. https://t.co/LOrcwDEa3V

[Cellistic @CellisticCT]

Our Senior VP Cell Therapy R&D Elena Matsa is presenting today at the Forum A3P in Charleroi. If you are attending the event, be sure to join her at 11:30 AM to discover the potential of iPSCs in cell therapy.

[Cellistic @CellisticCT]

Four key insights about next generation cell therapies - delve into the current landscape of adoptive cell therapies and its challenges, with experts Dr. Jo Brewer from Adaptimmune and our own founder and CTO Stefan Braam. Listen to the podcast: https://t.co/s9lx5cvdPx

[Cellistic @CellisticCT]

Our goal: to give our clients a critical speed advantage as they pursue their innovations, meaning patients get access to better therapies, faster. Your science deserves our best resources, so let’s get started today. Your beyond begins here. https://t.co/agohUkg25q

[Cellistic @CellisticCT]

At Cellistic, we exist to make the next generation of cell therapies far more accessible than they are today. And that starts with unlocking the potential of iPSC-based allogeneic cell therapies to overcome the limitations of today's cell therapies. https://t.co/O0xuQe7ykc

[Cellistic @CellisticCT]

At Cellistic, we have a singular focus on creating the best technology and manufacturing processes for your cell therapy. We can get you where you need to go—faster. Tap into platforms that let you plug-n-play and accelerate development with confidence: https://t.co/eHzqKX6U4C

[Cellistic @CellisticCT]

Cellistic reveals groundbreaking iPSC-based platforms to accelerate off-the-shelf allogeneic cell therapy development and manufacturing. Introducing the Pulse and Echo Platforms. Full story here: https://t.co/ggErenQo9q

#ipsc #celltherapy #allogeneiccelltherapy

[Cellistic @CellisticCT]

Are you looking for a new challenge in your #career? Look no further! We're a fast-growing company in the #celltherapy industry, and we're currently seeking talented individual. Join us and apply today! #vacancy
https://t.co/WeB3habE2u

[Cellistic @CellisticCT]

Turning #CellTherapy Challenges into Opportunities! Dive into Cellistic's journey of #iPSC differentiation and #GMP facility development. Learn how our capabilities help you navigate manufacturing challenges, ensuring your therapies reach patients faster: https://t.co/YRkmlcRcKB

[Cellistic @CellisticCT]

Especially #NK cell like derivatives have emerged in the #CellTherapy landscape, with 18 studies initiated in the past 5 years. With one of the main developments the use of #iPSCs. Read more about the #AllogeneicCellTherapy landscape and its' hurdles: https://t.co/JWxk0KoDZM

[Cellistic @CellisticCT]

In this podcast, Dr. Tracey Lodie, CSO at Quell Therapeutics, and our CCO Andy Holt share their thoughts on revolutionary cancer treatments in cell therapy derived from immune cells. Listen to the podcast to learn more: https://t.co/dsEdqH0rxQ